PT-141 is a molecule that binds to and activates the melanocortin receptors associated with skin pigmentation. Being that it
Currently, Bremelanotide PT-141 is administered via a subcutaneous injection, ideally where there are fat deposits. The only legitimate form of the peptide is injectable. Oral pills, nasal sprays, and creams have not been shown to be an effective means in which to administer Bremelanotide PT-141.
Given that everyone responds differently to Bremelanotide PT-141, effective dosages may vary. A 2mg dose is generally effective for men and women, about 1 hour prior to sexual activity. Some studies suggest starting with a 1mg test dose and injecting an identical amount 30 minutes later. By consulting your Men's Health Institute physician, you can receive a cycle protocol best suited for your condition. In studies, some subjects responded to PT-141 in minutes while others took several hours to see the effects.
Bremelanotide PT-141 is a novel treatment option for sexual dysfunction that works in both men and women.
The discovery of PT-141 as an agent of sexual activity enhancement was accidental and owes its debt to scientist Mac Hadley's generous volunteering of himself, as he was conducting experiments on his own body and ended up with an eight-hour erection as a result of a double dose of an early compound, Melanotan II, during the earliest testing. Melanocortins are peptide hormones responsible for regulating many physiological functions. Melanocortin analog, Melanotan I, was tested as a tanning agent, and Melanotan II as a sexual dysfunction agent.
